Stop Treating Patient Samples As Acceptable Losses

Patients do not enter clinical trials lightly. They give their time, accept risk, and often do so with the hope that their contribution will help advance medical research or provide access to a potential treatment option.

In this short webinar excerpt, Dr. Richard Graham pushes back on the idea that preventable biological sample loss should be tolerated as a routine part of trial execution. When blood or tissue samples are lost, switched, mishandled, or otherwise rendered unusable, the issue is bigger than operational inefficiency. It raises a harder question: Are we treating the patients every clinical trial depends on with the care their participation deserves?